How States, Federal Agencies Are Challenging Drug Prices
Law360 (April 23, 2018, 3:33 PM EDT) -- In recent years, prescription drug prices have become a focal point in the discussion of U.S. health care spending. While political rhetoric in many areas may imply some degree of consensus that prices generally are "too high," any agreement doesn't go much beyond this broad generalization.
It seems that everyone has a voice in the debate — not just consumer and patient advocacy groups, but manufacturers, payers, legislators, government agencies and even the president. However, with multiple different agendas and no uniform articulation of an underlying problem, the result has been a somewhat disjointed approach, with federal and state governments casting...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!